U.S. Officials Plead for More Use of Languishing Antibody Drugs
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis. U.S. health officials are pleading for more use of Covid-19 antibody therapies from Eli Lilly and Co. and Regeneron Pharmaceuticals Inc. that have been plagued by logistical issues, lack of efficacy data and insufficient […]
Read more